Browsing: sun pharma rating

Trend likely to continue; EPS for FY22e up 7.3%; Buy stays with unchanged TP of Rs 1030 Key points from…

SUNP’s Q2FY22 revenue, Ebitda and profit were 2%, 12% and 22% ahead of our estimates led by strong performance in…

Sun Pharma’s (SUNP) Q1FY22 income /EBITDA/ PAT beat consensus estimates by 11%/ 30%/ 40% as all corporations performed much better…